Computer-Aided Prevention System (CAPSYS)

January 20, 2016 updated by: Lübomira Spassova

Study on Improved Prevention Methods for Cerebro-cardiovascular Diseases Based on a Computer-aided Prevention System

Stroke is one of the most frequent and life-threatening diseases in Europe. About four stroke events occur per day in Luxembourg alone, and about 30% of these patients are affected by recurrent stroke within the following five years. Thus, new methods of primary and secondary prevention are needed to better control lifestyle-related risk factors.

The development and maintenance of a healthy lifestyle (smoking cessation, healthy nutrition, moderate physical exercises etc.) is a major objective concerning the primary and secondary prevention of cerebro- and cardiovascular diseases. CAPSYS is a computer-based lifestyle coaching system developed by researchers from the Public Research Centre (CRP) Henri Tudor in Luxembourg in collaboration with neurologists from the Centre Hospitalier de Luxembourg (CHL), which aims at supporting patients in performing appropriate behavior changes in order to minimize their individual risk factors. Patients can access CAPSYS by dialing a local-rate telephone number and answer to a set of previously known questions concerning their current nutrition, physical activity, blood pressure, smoking etc. In an interactive voice response approach, questions are issued by the system in natural language using text-to-speech, and the patient can provide the required values using the phone keypad. Based on the gathered values for each patient, the system automatically generates personalized verbal feedback at runtime and presents it to the patient during the phone dialog. Depending on the individual development of the patient's risk factors, the system feedback can contain advice for improvement, praise for healthy behavior and motivation to pursue a certain goal.

The user acceptance and effectiveness of the CAPSYS system is evaluated in a six-month randomized controlled study with participants recruited at CHL's neurology department.

Study Overview

Study Type

Interventional

Enrollment (Actual)

94

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At high risk of stroke:

    • Already suffered a stroke or Transient Ischemic Attack (TIA) or
    • At least two risk factors for stroke:

      • High blood pressure
      • Overweight
      • Low physical activity
      • Smoking
      • Unhealthy diet

Exclusion Criteria:

  • Inability to fill out or to understand the informed consent
  • No signed informed consent
  • Dementia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard care (SC)
Participants receive only the usual care including blood analyses, blood pressure controls and individual advice on healthy lifestyle during the outpatient treatment given by the neurologist, by the general practitioner and by other physicians.
Experimental: Interventional care (IC)
In addition to the usual care, patients are asked to call the CAPSYS system twice a week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Systolic Blood Pressure
Time Frame: baseline and 6 months
baseline and 6 months
Change in HDL Level
Time Frame: baseline and 6 months
baseline and 6 months
Change in LDL Level
Time Frame: baseline and 6 months
baseline and 6 months
Change in Triglyceride Level
Time Frame: baseline and 6 months
baseline and 6 months
Change in HbA1c Level
Time Frame: baseline and 6 months
baseline and 6 months
Change in Glycaemia Level
Time Frame: baseline and 6 months
baseline and 6 months
Change in BMI Value
Time Frame: baseline and 6 months
baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fruits and Vegetables Consumption
Time Frame: baseline and 6 months

Self-reported weekly portions of fruits and vegetables consumption

(During the recruiting interview, participants were instructed in estimating the size of a portion of fruits or vegetables and they were provided an information booklet on this topic.)

baseline and 6 months
Change in Whole Grain Food Consumption
Time Frame: baseline and 6 months

Self-reported weekly portions of whole grain food consumption

(During the recruiting interview, participants were instructed in estimating the size of a portion of whole grain food and they were provided an information booklet on this topic.)

baseline and 6 months
Change in Sweets Consumption
Time Frame: baseline and 6 months

Self-reported weekly portions of sweets consumption

(During the recruiting interview, participants were instructed in estimating the size of a portion of sweets and they were provided an information booklet on this topic.)

baseline and 6 months
Change in Duration of Physical Activity
Time Frame: baseline and 6 months
Self-reported weekly duration of physical activity of medium or high intensity
baseline and 6 months
Change in Quality of Life
Time Frame: baseline and 6 months

The QoL was measured using the standardised EQ-5D-5L instrument provided by the EuroQol Group.

In this context, the health value was specified by the participants on a subjective scale ranging from 0 ("The worst health you can imagine") to 100 ("The best health you can imagine").

baseline and 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability: SUS Score
Time Frame: 6 months

The usability of the intervention was assessed based on the standardised System Usability Scale (SUS).

SUS scores were not collected in the SC group because the SC participants were not using CAPSYS and hence were not able to assess its usability.

The System Usability Scale (SUS) provides a "quick and dirty", reliable tool for measuring the usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. Originally created by John Brooke in 1986, it allows to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications.

The total SUS score computed based on the responses provided to each of the 10 items can range from 0 (worst) to 100 (best). Based on research, a SUS score above a 68 would be considered above average and anything below 68 is below average.

6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Lübomira Spassova, Dr.-Ing., Luxembourg Institute of Science and Technology
  • Study Chair: Debora Vittore, Centre Hospitalier de Luxembourg (CHL)
  • Principal Investigator: Dirk W Droste, Prof. Dr., Centre Hospitalier de Luxembourg (CHL)
  • Study Director: Norbert Rösch, Prof. Dr., University of Applied Sciences Kaiserslautern

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

August 1, 2014

Study Registration Dates

First Submitted

May 12, 2015

First Submitted That Met QC Criteria

May 13, 2015

First Posted (Estimate)

May 14, 2015

Study Record Updates

Last Update Posted (Estimate)

February 18, 2016

Last Update Submitted That Met QC Criteria

January 20, 2016

Last Verified

January 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Standard care

3
Subscribe